HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo Monini Selected Research

Saquinavir (Invirase)

12/2020HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction.
5/2012Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity.
1/2011Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases.
9/2003Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth.
8/2003HIV protease inhibitors as new treatment options for Kaposi's sarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paolo Monini Research Topics

Disease

8Infections
08/2019 - 11/2002
8Acquired Immunodeficiency Syndrome (AIDS)
01/2014 - 04/2002
8Kaposi Sarcoma (Kaposi's Sarcoma)
02/2009 - 03/2002
7Neoplasms (Cancer)
12/2020 - 07/2002
7Disease Progression
08/2019 - 10/2008
3Viremia
01/2019 - 09/2002
2HIV Infections (HIV Infection)
12/2020 - 05/2012
2Carcinoma (Carcinomatosis)
12/2020 - 05/2012
2Uterine Cervical Dysplasia
12/2020 - 05/2012
1Asymptomatic Diseases
06/2016
1Adenocarcinoma
01/2011
1Lymphoma (Lymphomas)
09/2003
1Inflammation (Inflammations)
09/2003
1Neoplasm Metastasis (Metastasis)
09/2003
1Latent Infection
10/2002
1Herpesviridae Infections (Herpesvirus Infection)
07/2002
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
04/2002

Drug/Important Bio-Agent (IBA)

9HIV Protease InhibitorsIBA
12/2020 - 03/2002
6Indinavir (Crixivan)FDA Link
12/2020 - 08/2003
5Saquinavir (Invirase)FDA Link
12/2020 - 08/2003
5VaccinesIBA
08/2019 - 10/2008
4Matrix Metalloproteinases (MMPs)IBA
12/2020 - 01/2011
4AntibodiesIBA
08/2019 - 12/2009
3Ritonavir (Norvir)FDA Link
12/2020 - 09/2003
3Pharmaceutical PreparationsIBA
01/2014 - 02/2003
2CytokinesIBA
12/2020 - 11/2002
2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 01/2014
2Proteins (Proteins, Gene)FDA Link
05/2018 - 03/2009
2Virulence Factors (Pathogenicity Factors)IBA
01/2015 - 06/2014
2IntegrinsIBA
06/2014 - 01/2012
2Biomarkers (Surrogate Marker)IBA
01/2014 - 02/2009
2Protease Inhibitors (Protease Inhibitor)IBA
01/2011 - 09/2003
2tat Gene Products (tat Protein)IBA
12/2009 - 10/2008
2EpitopesIBA
01/2006 - 07/2002
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2020
1Estrogens (Estrogen)FDA Link
12/2020
1Tissue Inhibitor of Metalloproteinase-3IBA
12/2020
1LopinavirFDA Link
12/2020
1Peptide Hydrolases (Proteases)FDA Link
05/2018
1Trans-Activators (Trans-Acting Factor)IBA
01/2015
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2011
1Dihydrotachysterol (AT 10)IBA
09/2010
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2009
1Nelfinavir (Viracept)FDA Link
09/2003
1EnzymesIBA
02/2003
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
11/2002
1Interleukin-2 (IL2)IBA
09/2002
1Viral AntigensIBA
07/2002
1Interferon alpha-2 (Roferon-A)FDA Link
04/2002
1Human immunodeficiency virus 1 p16 proteaseIBA
03/2002

Therapy/Procedure

7Therapeutics
12/2020 - 04/2002
6Highly Active Antiretroviral Therapy (HAART)
08/2019 - 10/2002
1Immunotherapy
01/2006
1Aftercare (After-Treatment)
10/2002